Antiviral Agents: Clinical Trials

3 trials for Antiviral Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 3
Phase 21Terminated 1

Follow Antiviral Agents: new trials by email Literature Review of Antiviral Agents trials Research Report on Antiviral Agents

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
CYNK001-IV, CYNK001-IT - Astrocytoma, Grade IV, Giant Cell Glioblastoma
Phase 1TerminatedCelularity Incorporated32020-10-012022-08-10
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19
CYNK-001 - Coronavirus, Coronavirus Infection
Phase 1 / Phase 2TerminatedCelularity Incorporated72020-09-022026-06-26
Natural Killer Cell (CYNK-001) Infusions in Adults with AML
CYNK-001 - Leukemia, Leukemia, Myeloid
Phase 1TerminatedCelularity Incorporated272020-03-122024-12-12

Narrower conditions

COVID-19 (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Glioblastoma (1)  ·  Hematologic Diseases (1)  ·  Hematologic Neoplasms (1)  ·  Immune System Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lung Diseases (1)  ·  Neoplasm, Residual (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Nidovirales Infections (1)

Broader conditions

Astrocytoma (1)  ·  Glioma (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Infections (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neoplastic Processes (1)  ·  Neuroectodermal Tumors (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

Celularity Incorporated (3)

Countries

United States (3)

Top investigators

Corey Casper, MD MPH (1)  ·  Sharmila Koppisetti, M.D (1)  ·  Sharmila Koppisetti, MD (1)